SCHEMBL23903101

SCHEMBL23903101

Cn1c(N)c(C(N)=O)c2nc(C(C)(C)F)cnc21

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PKMYT1 Q99640 13/20 0.47
CYP2C9 P11712 3/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 1/20 0.35
EPHB4 P54760 6/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
WEE1 P30291 4/20 0.33
MYT1 Q01538 1/20 0.33
EPHB3 P54753 2/20 0.32
NR3C1 P04150 1/20 0.32
FYN P06241 1/20 0.32
EPHA3 P29320 1/20 0.32
CREBBP Q92793 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23903669 0.87 PKMYT1 (0.60) PKMYT1CYP2C9CYP3A4CYP2D6EPHB4
SCHEMBL23903337 0.78 PKMYT1 (0.37) PKMYT1CYP2C9CYP3A4CYP2D6EPHB4
SCHEMBL23903348 0.78 PKMYT1 (0.31) PKMYT1
SCHEMBL23903506 0.77 PKMYT1 (0.40) PKMYT1CYP2C9CYP3A4CYP2D6EPHB4
SCHEMBL23905698 0.77 PKMYT1 (0.37) PKMYT1CYP2C9CYP3A4CYP2D6EPHB4
SCHEMBL23905688 0.76 PKMYT1 (0.36) PKMYT1CYP2C9CYP3A4CYP2D6EPHB4
SCHEMBL29869546 0.76 PKMYT1 (0.83) PKMYT1CYP2C9CYP3A4CYP2D6WEE1
SCHEMBL23888207 0.76 PKMYT1 (0.83) PKMYT1CYP2C9CYP3A4CYP2D6WEE1
SCHEMBL24708599 0.75 PKMYT1 (0.41) PKMYT1CYP2C9CYP3A4CYP2D6WEE1
SCHEMBL23903339 0.75 PKMYT1 (0.46) PKMYT1CYP2C9CYP3A4CYP2D6EPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022213204-A9 CARBOXAMIDE PYROLOPYRAZINE AND PYRIDINE COMPOUNDS USEFUL AS INHIBITORS OF MYT1 AND USE THEREOF IN THE TREATMENT OF CANCER REPARE THERAPEUTICS INC. (CA) 2023-11-16 WO disclosed
WO-2022213204-A1 COMBINATION THERAPIES INCLUDING MYT1 INHIBITORS REPARE THERAPEUTICS INC. (CA) 2022-10-13 WO disclosed
WO-2021195782-A1 METHODS OF USING MYT1 INHIBITORS REPARE THERAPEUTICS INC. (CA) 2021-10-07 WO disclosed
WO-2021195781-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING COMPOUNDS AND OF THEIR USE REPARE THERAPEUTICS INC. (CA) 2021-10-07 WO disclosed